跳至主要内容
临床试验/CTRI/2020/04/024646
CTRI/2020/04/024646尚未招募4 期

An Open-label, single center, Non – Interventional, Observational Studyto Evaluate Efficacy and safety of Herbal nutritional Supplement(Cuminum cyminum, Zingiber officinale, Myristica fragrans, Elettariacardamomum, Linum usitatissimum, Psidium guajava ,Curcuma longa,Cinnamomum verum, Syzygium aromaticum, Glycyrrhiza glabra,Trigonella foenum-graecum, Foeniculum vulgare, Nigella sativa) inmanagement of hypertension and its associated risk factors

DIABLISS PVT LIMITED1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年4月30日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
efficacy of suppliment in 60 days in hypertesive patients and its management with basic parameters

研究概览

简要总结

This is a Non –Interventional Observational study. After obtaining informed consent frompatient for study participation, the doctor will prescribe the herbal nutritionalsupplement as part of routine clinical practice based on the doctor’sknowledge and experience. After four weeks of treatment the patient will be requested tovisit the hospital for follow-up. 

Atotal of 50 (25- subjects newhypertensive i.e <1 Year with HTN; 25 subjects with long term Hypertensivei.e >1 year  with HTN) subjects with age group >45years and surviving with standard medication should be considered to initiate treatment with Herbal nutritionalSupplement(Cuminum cyminum, Zingiber officinale, Myristica fragrans, Elettariacardamomum, Linum usitatissimum, Psidium guajava ,Curcuma longa, Cinnamomumverum, Syzygium aromaticum, Glycyrrhiza glabra, Trigonella foenum-graecum,Foeniculum vulgare, Nigella sativa) for a period of 6 months  to stusy the effucacy of the herbal suppliment in mange ment of hypertension

研究设计

研究类型
Observational

入排标准

年龄范围
40.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Male and female treatment naïve patients, aged >45 years, with diagnosis of hypertension (DBP 110 mm Hg and SBP >150mm Hg).

排除标准

  • Male and female treatment naïve patients, aged <45 years, with diagnosis of hypertension (.

结局指标

主要结局

efficacy of suppliment in 60 days in hypertesive patients and its management with basic parameters

时间窗: 30 days from the enrollment day

次要结局

  • efficacy of suppliment in 60 days in hypertesive patients and its management with parameters(8)

研究者

发起方
DIABLISS PVT LIMITED
申办方类型
Other [Conumer products Limited]

研究点 (1)

Loading locations...

相似试验